Bentham Science Logo

Track Your Manuscript:


Current Psychopharmacology

Volume 9, 3 Issues, 2020
ISSN: 2211-5579 (Online)
ISSN: 2211-5560 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Psychopharmacology, Volume 3 - Number 2


Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review of Recent Data

, 3(2): 93 - 107

Silvio Bellino, Marta Mirra, Elena Brignolo, Paola Bozzatello and Filippo Bogetto


DOI: 10.2174/2211556003666140618185450



Increase in Antipsychotic Polypharmacy Treatment in Patients with Schizophrenia Between 1994-2000 and 2010

, 3(2): 108 - 112

Deniz Ceylan, Ahmet Aktener, Berna B. Akdede and Koksal Alptekin


DOI: 10.2174/221155600302150302110310



A Review of the Current Clinical Use of Quetiapine and Extended Release Quetiapine in the Management of Anxiety and Related Disorders

, 3(2): 113 - 125

Martin A. Katzman, Melissa Furtado, Alexandra Copeland, Dina Tsirgielis, Christina D’Ambrosio, Leena Anand and Irvin Epstein


DOI: 10.2174/221155600302150302110735





Maternal Exposure to Quetiapine: Effects on Structural Changes in Developing Brain and its Lasting Impact on Neurobehavioral Impairments in Rat Offspring

, 3(2): 137 - 145

Krishna P. Singh and Nidhi Tripathi


DOI: 10.2174/2211556003666140618184858





Editor-in-Chief

Kenneth Blum
Western University of Health Sciences
Pomona, CA
(USA)

Biography View Full Editorial Board

Journal History

Current Psychopharmacology was launched in 2012. Dr. Kenneth Blum serves as the Editor-in-Chief of the journal.

Advertisement

Covid Resource Center

Related Journals

Related eBooks

eBooks Catalog